GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 103 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,310 | -41.5% | 19,366 | -33.7% | 0.00% | – |
| Q2 2023 | $56,932 | -24.1% | 29,196 | +59.4% | 0.00% | – |
| Q1 2022 | $75,000 | -75.0% | 18,314 | -21.5% | 0.00% | – |
| Q4 2021 | $300,000 | +27.7% | 23,343 | +7.1% | 0.00% | – |
| Q3 2021 | $235,000 | -53.7% | 21,787 | -60.9% | 0.00% | -100.0% |
| Q2 2021 | $508,000 | +18.7% | 55,675 | +22.7% | 0.00% | 0.0% |
| Q1 2021 | $428,000 | +141.8% | 45,392 | +1.3% | 0.00% | – |
| Q4 2020 | $177,000 | +48.7% | 44,805 | 0.0% | 0.00% | – |
| Q3 2020 | $119,000 | -60.1% | 44,805 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $298,000 | +30.1% | 44,805 | +14.1% | 0.00% | – |
| Q1 2020 | $229,000 | -34.2% | 39,277 | +1.1% | 0.00% | -100.0% |
| Q4 2019 | $348,000 | +3.9% | 38,833 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $335,000 | -21.5% | 38,833 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $427,000 | +196.5% | 38,369 | +254.3% | 0.00% | – |
| Q1 2019 | $144,000 | -25.8% | 10,828 | -13.5% | 0.00% | – |
| Q4 2018 | $194,000 | – | 12,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |